Global Monkeypox Virus Monoclonal Antibody Market Growth 2025-2031

The global Monkeypox Virus Monoclonal Antibody market size is predicted to grow from US$ 1459 million in 2025 to US$ 2520 million in 2031; it is expected to grow at a CAGR of 9.5% from 2025 to 2031.

Monkeypox virus monoclonal antibodies are highly homogeneous antibodies produced by a single B cell clone and target only a specific antigenic epitope of monkeypox virus.

United States market for Monkeypox Virus Monoclonal Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Monkeypox Virus Monoclonal Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Monkeypox Virus Monoclonal Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Monkeypox Virus Monoclonal Antibody players cover ProteoGenix, ACROBiosystems, Creative Diagnostics, Novus Biologicals, LLC, Merck Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Monkeypox Virus Monoclonal Antibody Industry Forecast” looks at past sales and reviews total world Monkeypox Virus Monoclonal Antibody sales in 2024, providing a comprehensive analysis by region and market sector of projected Monkeypox Virus Monoclonal Antibody sales for 2025 through 2031. With Monkeypox Virus Monoclonal Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monkeypox Virus Monoclonal Antibody industry.

This Insight Report provides a comprehensive analysis of the global Monkeypox Virus Monoclonal Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monkeypox Virus Monoclonal Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Monkeypox Virus Monoclonal Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monkeypox Virus Monoclonal Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monkeypox Virus Monoclonal Antibody.

This report presents a comprehensive overview, market shares, and growth opportunities of Monkeypox Virus Monoclonal Antibody market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Purity>90%
Purity>95%
Others

Segmentation by Application:
Diagnostic Laboratories
Research and Academic Laboratories
Pharmaceutical and Biotechnology Companies

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ProteoGenix
ACROBiosystems
Creative Diagnostics
Novus Biologicals, LLC
Merck Group
Absolute Antibody
Creative Biolabs
Sanyoubio
Cnpair
Vazyme
Sinobiological

Key Questions Addressed in this Report

What is the 10-year outlook for the global Monkeypox Virus Monoclonal Antibody market?

What factors are driving Monkeypox Virus Monoclonal Antibody market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Monkeypox Virus Monoclonal Antibody market opportunities vary by end market size?

How does Monkeypox Virus Monoclonal Antibody break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.